Because it inhibits the activity of a wide variety of well-known oncogenes, such as MYC, BCL-2, ERK, and AKT, the PP2A holoenzyme is considered a tumor suppressor (Lin et al., 2006; Ruvolo et al., 2011) (Figure 2). This evidence concerns the gene PTPA and neoplasm.